Outcomes of benign breast papillomas diagnosed at image-guided vacuum-assisted core needle biopsy

Hawley, Jeffrey R.; Lawther, Hannah; Erdal, Barbaros S.; Yıldız, Vedat; Çarkaci, Selin

doi:10.1016/j.clinimag.2015.01.017

Cited by 26 publications

(28 citation statements)

References 51 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although the management of benign papillary lesions diagnosed at CNBs is still controversial [2–6], the current management of benign papillary lesions diagnosed at CNBs is US-guided VAE [4–7]. Thus, predicting atypical or malignant papillary lesions on US could be helpful for the management.…”

Section: Discussionmentioning

confidence: 99%

“…Benign papillary lesions assessed as BI-RADS category 4A are generally enough to deal with US-guided VAE, whereas benign papillary lesions assessed as category 4C or 5 should be considered surgical excision in recent studies [4–7]. Regardless of BI-RADS assessment, atypical or malignant papillary lesions diagnosed at CNBs are recommended surgical excision [4–7].…”

Section: Discussionmentioning

confidence: 99%

“…Previous studies [2, 3] have reported that surgical excision is recommended for an accurate diagnosis of benign papilloma diagnosed using ultrasound (US)-guided CNB. In contrast, some studies have reported that US-guided vacuum-assisted excision (VAE) is accurate and could be an alternative to surgery for benign papillary lesions [4–7]. Sohn et al [4] reported no malignancies after excising benign papilloma diagnosed by US-guided CNB.…”

Section: Introductionmentioning

confidence: 99%

“…Ko et al [5] suggested that well-selected benign papilloma (category 3 or 4A papillary lesions < 1.5 cm) can be treated with US-guided VAE rather than surgical excision. Although management of breast papillary lesions is controversial, the current trend is to use US-guided VAE for well-selected benign papillary lesions diagnosed by US-guided CNB [4–7]. In contrast, papillary lesions with atypia should be treated by surgical excision [6, 7].…”

Section: Introductionmentioning

confidence: 99%

“…Although management of breast papillary lesions is controversial, the current trend is to use US-guided VAE for well-selected benign papillary lesions diagnosed by US-guided CNB [4–7]. In contrast, papillary lesions with atypia should be treated by surgical excision [6, 7]. Therefore, sub-analysis of breast papillary lesions is essential for managing patients.…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

Shear-Wave Elastography for the Differential Diagnosis of Breast Papillary Lesions

et al. 2016

View full text Add to dashboard Cite

ObjectiveTo evaluate the diagnostic performance of shear-wave elastography (SWE) for the differential diagnosis of breast papillary lesions.MethodsThis study was an institutional review board-approved retrospective study, with a waiver of informed consent. A total of 79 breast papillary lesions in 71 consecutive women underwent ultrasound and SWE prior to biopsy. Ultrasound features and quantitative SWE parameters were recorded for each lesion. All lesions were surgically excised or excised using an ultrasound-guided vacuum-assisted method. The diagnostic performances of the quantitative SWE parameters were compared using the area under the receiver operating characteristic curve (AUC).ResultsOf the 79 lesions, six (7.6%) were malignant and 12 (15.2%) were atypical. Orientation, margin, and the final BI-RADS ultrasound assessments were significantly different for the papillary lesions (p < 0.05). All qualitative SWE parameters were significantly different (p < 0.05). The AUC values for SWE parameters of benign and atypical or malignant papillary lesions ranged from 0.707 to 0.757 (sensitivity, 44.4–94.4%; specificity, 42.6–88.5%). The maximum elasticity and the mean elasticity showed the highest AUC (0.757) to differentiate papillary lesions.ConclusionSWE provides additional information for the differential diagnosis of breast papillary lesions. Quantitative SWE features were helpful to differentiate breast papillary lesions.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Shear-Wave Elastography for the Differential Diagnosis of Breast Papillary Lesions

et al. 2016

View full text Add to dashboard Cite

show abstract

Malignant upgrade rate and associated clinicopathologic predictors for concordant intraductal papilloma without atypia: A systematic review and meta‐analysis

Keating,

Cevik,

Hopkins

et al. 2024

Journal of Surgical Oncology

View full text Add to dashboard Cite

Previously reported upgrade rates for benign breast intraductal papilloma (IDP) are widely variable. However, many previous studies have failed to consider radiologic‐pathologic discordance of lesions. This review aims to synthesize malignant upgrade data for benign, concordant IDP at surgical excision. Thirteen studies were included in our meta‐analysis. The pooled estimate for percentage underestimation of carcinoma was 1.4% (95% CI: 0.8%−2.0%). We conclude that these lesions can be safely managed by active surveillance.

show abstract

Premalignant Disorders of the Breast in Pregnancy and Lactation

Omranipour

Alipour

Ensani

et al. 2020

Advances in Experimental Medicine and Biology

View full text Add to dashboard Cite

Outcomes of benign breast papillomas diagnosed at image-guided vacuum-assisted core needle biopsy

Cited by 26 publications

References 51 publications

Shear-Wave Elastography for the Differential Diagnosis of Breast Papillary Lesions

Shear-Wave Elastography for the Differential Diagnosis of Breast Papillary Lesions

Malignant upgrade rate and associated clinicopathologic predictors for concordant intraductal papilloma without atypia: A systematic review and meta‐analysis

Premalignant Disorders of the Breast in Pregnancy and Lactation

Contact Info

Product

Resources

About